|
1
|
Becker C, Fantini MC, Wirtz S, Nikolaev A,
Lehr HA, Galle PR, Rose-John S and Neurath MF: IL-6 signaling
promotes tumor growth in colorectal cancer. Cell Cycle. 4:217–220.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith AR, Marquez RT, Tsao WC, Pathak S,
Roy A, Ping J, Wilkerson B, Lan L, Meng W, Neufeld KL, et al: Tumor
suppressive microRNA-137 negatively regulates Musashi-1 and
colorectal cancer progression. Oncotarget. 6:12558–12573. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Research Council (US) Committee
on A Framwework for Developing a New Taxonomy of Disease, . Toward
Precision Medicine: Building a Knowledge Network for Biomedical
Research and a New Taxonomy of Disease. National Academies Press
(US); Washington (DC): 2011
|
|
5
|
Mirnezami R, Nicholson J and Darzi A:
Preparing for precision medicine. N Engl J Med. 366:489–491. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hosono K, Yamada E, Endo H, Takahashi H,
Inamori M, Hippo Y, Nakagama H and Nakajima A: Increased tumor
necrosis factor receptor 1 expression in human colorectal adenomas.
World J Gastroenterol. 18:5360–5368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seitz C, Muller P, Krieg RC, Mannel DN and
Hehlgans T: A novel p75TNF receptor isoform mediating NFkappa B
activation. J Biol Chem. 276:19390–19395. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ,
Liu GY, Syed NM, Lai Y, Lin EA, Kong L, et al: The growth factor
progranulin binds to TNF receptors and is therapeutic against
inflammatory arthritis in mice. Science. 332:478–484. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo Z, Li Q, Han Y, Liang Y, Xu Z and Ren
T: Prevention of LPS-induced acute lung injury in mice by
progranulin. Mediators Inflamm. 2012:5407942012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao YP, Tian QY, Frenkel S and Liu CJ:
The promotion of bone healing by progranulin, a downstream molecule
of BMP-2, through interacting with TNF/TNFR signaling.
Biomaterials. 34:6412–6421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tanimura Y, Kokuryo T, Tsunoda N, Yamazaki
Y, Oda K, Nimura Y, Mon N Naing, Huang P, Nakanuma Y, Chen MF, et
al: Tumor necrosis factor alpha promotes invasiveness of
cholangiocarcinoma cells via its receptor, TNFR2. Cancer Lett.
219:205–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szlosarek PW and Balkwill FR: Tumour
necrosis factor alpha: A potential target for the therapy of solid
tumours. Lancet Oncol. 4:565–573. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jöhrer K, Janke K, Krugmann J, Fiegl M and
Greil R: Transendothelial migration of myeloma cells is increased
by tumor necrosis factor (TNF)-alpha via TNF Receptor 2 and
autocrine Up-regulation of MCP-1. Clin Cancer Res. 10:1901–1910.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arnott CH, Scott KA, Moore RJ, Robinson
SC, Thompson RG and Balkwill FR: Expression of both TNF-alpha
receptor subtypes is essential for optimal skin tumour development.
Oncogene. 23:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baud V and Karin M: Signal transduction by
tumor necrosis factor and its relatives. Trends Cell Biol.
11:372–377. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grell M, Zimmermann G, Hülser D,
Pfizenmaier K and Scheurich P: TNF receptors TR60 and TR80 can
mediate apoptosis via induction of distinct signal pathways. J
Immunol. 153:1963–1972. 1994.PubMed/NCBI
|
|
17
|
Dahlmann M, Okhrimenko A, Marcinkowski P,
Osterland M, Herrmann P, Smith J, Heizmann CW, Schlag PM and Stein
U: RAGE mediates S100A4-induced cell motility via MAPK/ERK and
hypoxia signaling and is a prognostic biomarker for human
colorectal cancer metastasis. Oncotarget. 5:3220–3233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu SY, Tai CC, Li YH and Wu JL:
Progranulin compensates for blocked IGF-1 signaling to promote
myotube hypertrophy in C2C12 myoblasts via the PI3K/Akt/mTOR
pathway. FEBS Lett. 586:3485–3492. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai T, Lian LH, Wu YL, Wan Y and Nan JX:
Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling
pathways in activated hepatic stellate cells. Int Immunopharmacol.
15:275–281. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li N, Cui J, Duan X, Chen H and Fan F:
Suppression of type I collagen expression by miR-29b via PI3K, Akt,
and Sp1 pathway in human Tenon's fibroblasts. Invest Ophthalmol Vis
Sci. 53:1670–1678. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miao B and Degterev A: Targeting
phospshatidylinositol 3-kinase signaling with novel
phosphatidylinositol 3,4,5-triphosphate antagonists. Autophagy.
7:650–651. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gentilini A, Marra F, Gentilini P and
Pinzani M: Phosphatidylinositol-3 kinase and extracellular
signal-regulated kinase mediate the chemotactic and mitogenic
effects of insulin-like growth factor-I in human hepatic stellate
cells. J Hepatol. 32:227–234. 2000. View Article : Google Scholar : PubMed/NCBI
|
